UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Journal of clinical oncology, 2009-06, Vol.27 (18), p.2954-2961

2009

Link zum Volltext

Verfügbarkeit prüfen

Dual light field and polarization imaging using CMOS diffractive image sensors

Optics letters, 2015-05, Vol.40 (10), p.2433-2436

2015

Link zum Volltext

Verfügbarkeit prüfen

Structural Analysis of CTLA-4 Function In Vivo

The Journal of immunology (1950), 2000-05, Vol.164 (10), p.5319-5327

2000

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Subtypes in Asian-Americans Differ According to Asian Ethnic Group

Journal of immigrant and minority health, 2012-10, Vol.14 (5), p.754-758

2012

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Invasive Ductal Carcinoma and Chronic Lymphocytic Leukemia Manifesting as a Collision Tumor in Breast

The breast journal, 2007-07, Vol.13 (4), p.413-417

2007

Link zum Volltext

Verfügbarkeit prüfen

Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205

Science translational medicine, 2014-04, Vol.6 (232), p.232ra51

2014

Link zum Volltext

Verfügbarkeit prüfen

Transgenic Expression of CTLA-4 Controls Lymphoproliferation in IL-2-Deficient Mice

The Journal of immunology (1950), 2004-11, Vol.173 (9), p.5415-5424

2004

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine‐mediated inhibitory signals contribute to CTLA‐4 function in vivo

International immunology, 2004-04, Vol.16 (4), p.539-547

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy

Clinical breast cancer, 2015-10, Vol.15 (5), p.332-334

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Clinical cancer research, 2016-01, Vol.22 (2), p.301-309

2016

Link zum Volltext

Verfügbarkeit prüfen

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

BMC cancer, 2015-04, Vol.15 (1), p.267-267, Article 267

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

Breast cancer research and treatment, 2008, Vol.107 (1), p.133-138

2008

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.OT1-1-09-OT1-1-09

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular Basis of T Cell Inactivation by CTLA-4

Science (American Association for the Advancement of Science), 1998-12, Vol.282 (5397), p.2263-2266

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS666-TPS666

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-19-08: IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-19-08

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-19-27: IMMU-132, a new antibody-drug conjugate (ADC) against Trop-2, as a novel therapeutic for patients with relapsed/refractory, metastatic, triple-negative breast cancer (TNBC): Results from Phase I/II clinical trial (NCT01631552)

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-19-27

2015

Link zum Volltext

Verfügbarkeit prüfen

Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients

Breast cancer research and treatment, 2012-02, Vol.132 (1), p.235-242

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT206: SN-38 antibody-drug conjugate (ADC) targeting Trop-2, IMMU-132, as a novel platform for the therapy of diverse metastatic solid cancers: Initial clinical results

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT206-CT206

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT309: Influencing the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.CT309-CT309

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of scalp cryotherapy in preventing alopecia among patients with breast cancer patients receiving adjuvant docetaxel and cyclophosphamide

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20641-e20641

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose-dependent pharmacokinetic (PK) interaction of pegylated liposomal doxorubicin (PLD) with escalating doses of veliparib in a phase I study

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2591-2591

2013

Link zum Volltext

Verfügbarkeit prüfen

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A

Immunity (Cambridge, Mass.), 2000-09, Vol.13 (3), p.313-322

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(82)
Tagungsberichte
(1)

Sprache

Englisch
(83)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Humans
(39)
Life Sciences & Biomedicine
(38)
Female
(22)
Middle Aged
(14)
Aged
(12)
Male
(11)
Oncology
(11)
Science & Technology - Other Topics
(11)
Adult
(10)
Breast Cancer
(10)
Multidisciplinary Sciences
(10)
Alzheimer's Disease
(9)
Animals
(9)
Biological And Medical Sciences
(8)
Breast Neoplasms - Pathology
(8)
Biomarkers
(7)
Cognitive Ability
(7)
Ctla-4 Antigen
(7)
Immunology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Dual light field and polarization imaging using CMOS diffractive image sensors

Structural Analysis of CTLA-4 Function In Vivo

Breast Cancer Subtypes in Asian-Americans Differ According to Asian Ethnic Group

Concurrent Invasive Ductal Carcinoma and Chronic Lymphocytic Leukemia Manifesting as a Collision Tumor in Breast

Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Transgenic Expression of CTLA-4 Controls Lymphoproliferation in IL-2-Deficient Mice

Tyrosine‐mediated inhibitory signals contribute to CTLA‐4 function in vivo

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer

Molecular Basis of T Cell Inactivation by CTLA-4

Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer

Abstract P5-19-08: IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results

Abstract P5-19-27: IMMU-132, a new antibody-drug conjugate (ADC) against Trop-2, as a novel therapeutic for patients with relapsed/refractory, metastatic, triple-negative breast cancer (TNBC): Results from Phase I/II clinical trial (NCT01631552)

Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients

Abstract CT206: SN-38 antibody-drug conjugate (ADC) targeting Trop-2, IMMU-132, as a novel platform for the therapy of diverse metastatic solid cancers: Initial clinical results

Abstract CT309: Influencing the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence

Efficacy of scalp cryotherapy in preventing alopecia among patients with breast cancer patients receiving adjuvant docetaxel and cyclophosphamide

Dose-dependent pharmacokinetic (PK) interaction of pegylated liposomal doxorubicin (PLD) with escalating doses of veliparib in a phase I study

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A

Suchergebnisse filtern